Clinical trials recruiting in Anyang, South Korea

Phase breakdown

Conditions recruiting in Anyang, South Korea

Recruiting trials in Anyang, South Korea

• A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers
  NCT07682948 · Phase: Phase 1 · Ages: 19 Years to 54 Years · Sex: All (male and female)
• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
  NCT07784725 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
  NCT05841472 · Phase: Phase 2 · Ages: 19 Years to 80 Years · Sex: All (male and female)
• Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
  NCT06772168 · Phase: Phase 3 · Ages: 19 Years to 80 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Anyang, South Korea?

4 recruiting trials have at least one study site in Anyang, South Korea.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.